Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With Cancer
Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With Cancer
The goal of this clinical trial is to learn if the use of virtual reality during chemotherapy treatment helps participants achieve an improvement in distress, which may include unpleasant experience, anxiety, depression and/or pain.
Participants will:
Be randomly assigned to one of two available groups (virtual reality or standard of care)
Participations will only be during one chemotherapy session.
Those assigned to virtual reality:
Those assigned to the standard of care:
In recent decades, new cancer cases have consistently risen. Participants diagnosed with cancer commonly face psychological symptoms including distress, anxiety, and depression in addition to physical symptoms (i.e., pain). Importantly, these symptoms might be exacerbated during chemotherapy sessions. New innovative technological strategies have been under development to control the symptoms and improve quality of life. Immersive virtual reality (VR) is a simulated experience that enables participants to interact with an artificial three-dimensional visual and auditory environment. VR could be an innovative intervention to relieve psychological symptoms associated with chemotherapy.
Inclusion Criteria:
Exclusion Criteria: